NCT05665348 2026-03-09
TRIPLET
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
Clinical Trials
56 trialsNCT06904170 2026-02-03
ALICE
UNICANCER
Phase 2/3 Recruiting
NCT07309419 2025-12-30
Cocktail-001
Shanghai Zhongshan Hospital
Phase 2/3 Not yet recruiting
NCT07293468 2025-12-19
BIIRTH
Tuen Mun Hospital
Phase 2/3 Recruiting
NCT05171166 2025-12-18
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Peking University
Phase 2/3 Terminated
NCT05033522 2025-10-23
ALIVE
Mirror Biologics, Inc.
Phase 2/3 Suspended
NCT06007846 2025-09-30
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Phase 2/3 Recruiting
NCT06644937 2025-09-23
Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
Zhujiang Hospital
Phase 2/3 Recruiting
NCT06109272 2025-08-15
LIVIGNO-2
AbbVie
Phase 2/3 Recruiting
NCT06999512 2025-05-31
HPB70+
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Not yet recruiting
NCT04521153 2025-05-11
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 2/3 Active not recruiting
NCT06911086 2025-04-04
SH-LPS System in Preoperative Planning for Liver Resection
Zhejiang Cancer Hospital
Phase 2/3 Not yet recruiting
NCT04268888 2025-02-26
TACE-3
The Clatterbridge Cancer Centre NHS Foundation Trust
Phase 2/3 Suspended
NCT06796803 2025-02-10
Camrelizumab Combined with Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) As Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)
Shanghai Zhongshan Hospital
Phase 2/3 Not yet recruiting
NCT04560894 2024-02-01
HCC
Sinocelltech Ltd.
Phase 2/3 Unknown
NCT05062837 2024-01-23
Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC
Guangxi Medical University
Phase 2/3 Unknown
NCT05250843 2023-10-13
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2/3 Unknown
NCT05976568 2023-08-04
A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
Qilu Pharmaceutical Co., Ltd.
Phase 2/3 Not yet recruiting
NCT04797884 2023-06-28
ARTEMIS
THERABIONIC INC.
Phase 2/3 Unknown
NCT03859128 2023-03-31
JUPITER 04
Shanghai Junshi Bioscience Co., Ltd.
Phase 2/3 Unknown
NCT05408221 2023-03-10
HCC
Shandong New Time Pharmaceutical Co., LTD
Phase 2/3 Recruiting
NCT05344924 2022-12-29
TACE Combined With Penpulimab and Anlotinib for Advanced HCC
Zhongda Hospital
Phase 2/3 Unknown
NCT05544253 2022-09-16
Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC
West China Hospital
Phase 2/3 Unknown
NCT02794337 2022-04-27
TACE-SBRT
Tata Memorial Hospital
Phase 2/3 Unknown
NCT01164202 2022-03-18
SATURNE
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT04909866 2021-06-02
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2/3 Unknown
NCT04167293 2021-03-23
ISBRT01
Sun Yat-sen University
Phase 2/3 Unknown
NCT02851784 2021-03-04
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
Chinese PLA General Hospital
Phase 2/3 Completed
NCT03794440 2021-01-22
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2/3 Unknown
NCT03592706 2020-04-16
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Ivy Life Sciences, Co., Ltd
Phase 2/3 Unknown
NCT04319484 2020-03-24
LLTHVV
RenJi Hospital
Phase 2/3 Unknown
NCT04044651 2020-01-09
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Sun Yat-sen University
Phase 2/3 Withdrawn
NCT04168944 2019-11-19
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
RenJi Hospital
Phase 2/3 Unknown
NCT04025437 2019-09-04
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
Guangxi Medical University
Phase 2/3 Unknown
NCT02527772 2019-06-04
LD-FOX4/HCC
Guangxi Medical University
Phase 2/3 Withdrawn
NCT02534337 2019-06-04
Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma
Guangxi Medical University
Phase 2/3 Withdrawn
NCT02584556 2019-06-04
Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma
Guangxi Medical University
Phase 2/3 Withdrawn
NCT02585479 2019-06-04
Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma
Guangxi Medical University
Phase 2/3 Withdrawn
NCT02220088 2019-01-11
The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial
Sun Yat-sen University
Phase 2/3 Terminated
NCT01932385 2018-02-14
Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
Qingdao Central Hospital
Phase 2/3 Completed
NCT01901692 2017-09-18
START
Asan Medical Center
Phase 2/3 Completed
NCT02767375 2017-08-10
HAICAT
Peking University Cancer Hospital & Institute
Phase 2/3 Unknown
NCT01964001 2016-06-15
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer
Taichung Veterans General Hospital
Phase 2/3 Completed
NCT00814242 2016-04-01
Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT00820339 2016-04-01
SHVE
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT00827554 2016-04-01
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT02702323 2016-03-08
Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study
Zhejiang Cancer Hospital
Phase 2/3 Unknown
NCT02240771 2014-09-16
Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
All India Institute of Medical Sciences
Phase 2/3 Unknown
NCT00328770 2013-06-24
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
University of Alberta
Phase 2/3 Completed
NCT01861912 2013-06-05
ACTION
Guangdong Provincial People's Hospital
Phase 2/3 Unknown